R01DE029553
Project Grant
Overview
Grant Description
Microengineering Vascularized and Innervated Bone-Like Scaffolds as an Alternative to Autologous Bone Grafts - Project Summary
A wide range of skeletal conditions require assisted bone repair, including trauma, cancer resections, and bone augmentation for oral implant therapy. Current methods to treat these conditions rely on procedures to harvest and implant bone autografts, which are costly, invasive, and difficult to scale up. The other alternatives are synthetic bone replacement materials, which show high failure rates and fail to mimic the native bone structure, composition, and osteogenic properties.
Stem cell-based tissue engineering has long been proposed as a promising alternative for the repair of bone defects. However, treating large bony structures remains problematic. It is generally believed that scaffold materials that closely approximate the characteristics of native bone represent improved materials for bone regeneration. However, the development of in-vitro scaffolds mimicking the highly vascularized, innervated, and mineralized cell-rich bone matrix down to the nanoscale has remained elusive to date.
Here, we will develop a new bone scaffold biomanufacturing process where osteoprogenitor cells are three-dimensionally embedded in controlled nano-mineralized, pre-vascularized, and innervated bone-like injectable microgels, thus mimicking the mineralized nanostructure, cellular, and extracellular microenvironment of native bone.
(Aim 1) We will determine the mechanistic characteristics enabling the differentiation of HMSCs into osteogenic phenotypes as influenced by bone-like microenvironments and engineer cell-laden mineralized injectable microgels that approximate the regenerative potential of autologous bone grafts. We will then adapt this strategy to engineer
(Aim 2) pericyte-supported vascular capillaries and
(Aim 3) neuronal networks that are embedded in nanoscale mineralized hydrogels to determine the mechanisms that enable vascularity and innervation enhancement of osteogenesis in-vitro and regeneration in-vivo.
We argue that this multi-pronged strategy will enable the engineering of highly innovative bone scaffold materials and in-vitro bone model systems that will share great nanostructural and physical similarities to native bone. Ultimately, this will lead to biomaterials that closely approximate the regenerative potential of autologous bone in the clinic.
A wide range of skeletal conditions require assisted bone repair, including trauma, cancer resections, and bone augmentation for oral implant therapy. Current methods to treat these conditions rely on procedures to harvest and implant bone autografts, which are costly, invasive, and difficult to scale up. The other alternatives are synthetic bone replacement materials, which show high failure rates and fail to mimic the native bone structure, composition, and osteogenic properties.
Stem cell-based tissue engineering has long been proposed as a promising alternative for the repair of bone defects. However, treating large bony structures remains problematic. It is generally believed that scaffold materials that closely approximate the characteristics of native bone represent improved materials for bone regeneration. However, the development of in-vitro scaffolds mimicking the highly vascularized, innervated, and mineralized cell-rich bone matrix down to the nanoscale has remained elusive to date.
Here, we will develop a new bone scaffold biomanufacturing process where osteoprogenitor cells are three-dimensionally embedded in controlled nano-mineralized, pre-vascularized, and innervated bone-like injectable microgels, thus mimicking the mineralized nanostructure, cellular, and extracellular microenvironment of native bone.
(Aim 1) We will determine the mechanistic characteristics enabling the differentiation of HMSCs into osteogenic phenotypes as influenced by bone-like microenvironments and engineer cell-laden mineralized injectable microgels that approximate the regenerative potential of autologous bone grafts. We will then adapt this strategy to engineer
(Aim 2) pericyte-supported vascular capillaries and
(Aim 3) neuronal networks that are embedded in nanoscale mineralized hydrogels to determine the mechanisms that enable vascularity and innervation enhancement of osteogenesis in-vitro and regeneration in-vivo.
We argue that this multi-pronged strategy will enable the engineering of highly innovative bone scaffold materials and in-vitro bone model systems that will share great nanostructural and physical similarities to native bone. Ultimately, this will lead to biomaterials that closely approximate the regenerative potential of autologous bone in the clinic.
Funding Goals
NIDCR EXTRAMURAL RESEARCH PROVIDES RESEARCH FUNDS TO SUPPORT BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH IN DENTAL, ORAL, AND CRANIOFACIAL HEALTH AND DISEASE THROUGH GRANTS, COOPERATIVE AGREEMENTS, AND CONTRACTS THAT SUPPORT SCIENTISTS WORKING IN INSTITUTIONS THROUGHOUT THE UNITED STATES AND INTERNATIONALLY. EXTRAMURAL PROGRAMS PLAN, DEVELOP, AND MANAGE SCIENTIFIC PRIORITIES THROUGH PORTFOLIO ANALYSES AND CONSULTATION WITH STAKEHOLDERS, ENCOURAGING THE MOST PROMISING DISCOVERIES AND EMERGING TECHNOLOGIES FOR RAPID TRANSLATION TO CLINICAL APPLICATIONS. THE INTEGRATIVE BIOLOGY AND INFECTIOUS DISEASES PROGRAMS SUPPORTS BASIC AND TRANSLATIONAL RESEARCH PROGRAMS ON ORAL MICROBIOLOGY, SALIVARY BIOLOGY AND IMMUNOLOGY, ORAL AND SALIVARY GLAND CANCERS, NEUROSCIENCE OF OROFACIAL PAIN AND TEMPOROMANDIBULAR DISORDERS, MINERALIZED TISSUE PHYSIOLOGY, DENTAL BIOMATERIALS, AND TISSUE ENGINEERING AND REGENERATIVE MEDICINE. THE BRANCH AIMS TO ACCELERATE PROGRESS IN BASIC AND TRANSLATIONAL RESEARCH IN THESE AREAS, AND FURTHER STIMULATE THE DISCOVERY PIPELINE BASED ON CLINICAL NEEDS. THE TRANSLATIONAL GENOMICS RESEARCH PROGRAMS SUPPORTS BASIC AND TRANSLATIONAL RESEARCH IN GENETICS, GENOMICS, DEVELOPMENTAL BIOLOGY, AND DATA SCIENCE TOWARD THE GOAL OF IMPROVING DENTAL, ORAL, AND CRANIOFACIAL HEALTH. THE FOCUS IS ON DECIPHERING THE GENETIC, MOLECULAR, AND CELLULAR MECHANISMS UNDERLYING DENTAL, ORAL, AND CRANIOFACIAL DEVELOPMENT AND ANOMALIES. THE BEHAVIORAL AND SOCIAL SCIENCES RESEARCH PROGRAMS SUPPORTS BASIC AND APPLIED RESEARCH TO PROMOTE ORAL HEALTH, TO PREVENT ORAL DISEASES AND RELATED DISABILITIES, AND TO IMPROVE MANAGEMENT OF CRANIOFACIAL CONDITIONS, DISORDERS, AND INJURY. THE PROGRAM PRIORITIZES MECHANISTIC RESEARCH THAT CONTRIBUTES TO A CUMULATIVE SCIENCE OF BEHAVIOR CHANGE, TO MAXIMIZE THE RIGOR, RELEVANCE, AND DISSEMINATION OF EFFICACIOUS BEHAVIOR CHANGE INTERVENTIONS. THE CLINICAL RESEARCH PROGRAMS SUPPORTS PATIENT-ORIENTED, POPULATION, AND COMMUNITY BASED RESEARCH AIMED AT IMPROVING THE DENTAL, ORAL, AND CRANIOFACIAL HEALTH OF THE NATION. THE CENTER FOCUSES ON A VARIETY OF DISEASES AND CONDITIONS THROUGH CLINICAL TRIALS, EPIDEMIOLOGIC STUDIES, PRACTICE-BASED RESEARCH, THE HIV/AIDS AND ORAL HEALTH PROGRAM, AND STUDIES OF ORAL HEALTH DISPARITIES AND INEQUITIES IN ALL AREAS OF NIDCR PROGRAMMATIC INTEREST. THE PROGRAM ENCOURAGES INVESTIGATIONS THAT HAVE THE POTENTIAL TO TRANSLATE FINDINGS INTO EVIDENCE-BASED CLINICAL APPLICATIONS. THE RESEARCH TRAINING AND CAREER DEVELOPMENT EXTRAMURAL PROGRAMS SPAN THE CAREER STAGES OF SCIENTISTS, SUPPORTING RESEARCH TRAINING AND CAREER DEVELOPMENT FOR PHD AND DUAL DEGREE DDS/DMD-PHD STUDENTS, POSTDOCTORAL SCHOLARS, AND EARLY CAREER, MIDCAREER, AND ESTABLISHED INVESTIGATORS. THE PROGRAMS MANAGE SUPPORT FOR FELLOWSHIPS, RESEARCH TRAINING GRANTS, CAREER DEVELOPMENT AND CAREER TRANSITION AWARDS, NIH LOAN REPAYMENT AWARDS, AND DIVERSITY SUPPLEMENTS TO SUPPORT RESEARCH EXPERIENCES FOR HIGH SCHOOL STUDENTS THROUGH INVESTIGATORS. NIDCR PARTICIPATES IN THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) AND SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS. THE SBIR PROGRAM IS INTENDED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.THE STTR PROGRAM IS INTENDED TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. EXTRAMURAL PROGRAMS ARE ACCOUNTABLE FOR THE EFFICIENT AND EFFECTIVE USE OF TAXPAYER FUNDS TO SUPPORT RESEARCH ON DENTAL, ORAL, AND CRANIOFACIAL DISEASES AND DISORDERS AND IMPROVING THE ORAL HEALTH OF ALL AMERICANS. EXTRAMURAL PROGRAMS SUPPORT RESEARCH AND RESEARCH TRAINING TO ESTABLISH THE FOUNDATION FOR SCIENTIFIC DISCOVERIES THAT INCLUDE TRANSPARENT AND RIGOROUS PLANNING, PRIORITY SETTING, CONTINUOUS AND CONSISTENT REVIEWS OF PROGRESS, AND FOCUS ON THE DEVELOPMENT OF A DIVERSE, HIGHLY SKILLED, AND NIMBLE WORKFORCE THAT CAN RAPIDLY RESPOND TO SCIENTIFIC BREAKTHROUGHS AND PUBLIC HEALTH CHALLENGES. EXTRAMURAL PROGRAMS ARE ACCOUNTABLE FOR THE EFFICIENT AND EFFECTIVE USE OF TAXPAYER FUNDS TO SUPPORT RESEARCH ON DENTAL, ORAL, AND CRANIOFACIAL DISEASES AND EMPLOY EVALUATION DOMAINS, FROM NEEDS ASSESSMENT AND STRATEGIC PLANNING TO IMPLEMENTATION AND PROCESS EVALUATION, PERFORMANCE MEASUREMENT, AND OUTCOMES AND IMPACT ANALYSIS TO EVALUATE STRATEGIC OBJECTIVES
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Portland,
Oregon
972393011
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 387% from $626,418 to $3,048,776.
Oregon Health & Science University was awarded
Nanostructured Vascularized Bone-Like Scaffolds Enhanced Bone Regeneration
Project Grant R01DE029553
worth $3,048,776
from the National Institute of Dental and Craniofacial Research in August 2021 with work to be completed primarily in Portland Oregon United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.121 Oral Diseases and Disorders Research.
The Project Grant was awarded through grant opportunity Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/5/25
Period of Performance
8/1/21
Start Date
4/30/26
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01DE029553
Transaction History
Modifications to R01DE029553
Additional Detail
Award ID FAIN
R01DE029553
SAI Number
R01DE029553-2063611435
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NP00 NIH National Institute of Dental & Craniofacial Research
Funding Office
75NP00 NIH National Institute of Dental & Craniofacial Research
Awardee UEI
NPSNT86JKN51
Awardee CAGE
0YUJ3
Performance District
OR-01
Senators
Jeff Merkley
Ron Wyden
Ron Wyden
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Dental and Craniofacial Research, National Institutes of Health, Health and Human Services (075-0873) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,214,887 | 100% |
Modified: 6/5/25